AMZN
Amazon.com, Inc.
AMZN has the edge over MHK overall, supported by stronger valuation and stronger modeled upside.
MHK
Mohawk Industries, Inc.
MHK offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
MHK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Healthy |
MHK's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over MHK in the historical PE scenario, which offers more potential upside but is not a forecast.
MHK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.3x | $79.26 | -46% |
| Fair | 15x | $126 | -14% |
| Forward | 16x | $147 | — |
| Current | 17x | $147 | — |
| Expensive | 21x | $182 | +24% |
Historical ranges are pointers, not guarantees.
MHK's PE is in its expensive range at 17x. On analysts' estimates for next year's earnings, today's price would be 16x, in its fair range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
MHK Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect MHK's earnings, revenue and profitability to hold roughly steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over MHK on earnings, with more consistent year-over-year improvement.
MHK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.11 | +6.8% |
| Q3 2026 | $8.53 | +27% |
| Q2 2026 | $7.56 | +0.4% |
| Q1 2026 | $6.68 | -13% |
| Q4 2025 | $5.93 | -27% |
| Q3 2025 | $6.73 | -24% |
| Q2 2025 | $7.53 | +$13.17 |
| Q1 2025 | $7.65 | +$14.17 |
| Q4 2024 | $8.14 | +$15.04 |
MHK's earnings per share have fallen from their peak: $8.53 over the past year, against $15.60 in late 2021.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over MHK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over MHK on profitability, with a higher operating margin.
MHK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.8B | +1% |
| Q2 2026 | $3B | +6.8% |
| Q1 2026 | $2.7B | +8% |
| Q4 2025 | $2.7B | +2.4% |
| Q3 2025 | $2.8B | +1.4% |
| Q2 2025 | $2.8B | 0% |
| Q1 2025 | $2.5B | -5.7% |
| Q4 2024 | $2.6B | +1% |
MHK's revenue has grown year over year for six quarters in a row: $2.8B last quarter, up 1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.7% | +1.8 points |
| Q2 2026 | 8.5% | +1.8 points |
| Q1 2026 | 4.1% | +0.3 points |
| Q4 2025 | 2.5% | -2.1 points |
| Q3 2025 | 5% | -2.8 points |
| Q2 2025 | 6.7% | -0.9 points |
| Q1 2025 | 3.8% | -1.7 points |
| Q4 2024 | 4.6% | -1.8 points |
MHK's operating margin was 6.7% last quarter, up 1.8 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
MHK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $390.3M | +26% |
| Q2 2026 | $228.2M | +81% |
| Q1 2026 | $7.8M | +$93.2M |
| Q4 2025 | $265.2M | +12% |
| Q3 2025 | $310.3M | +52% |
| Q2 2025 | $126.1M | -11% |
| Q1 2025 | -$85.4M | -188% |
| Q4 2024 | $236.2M | +322% |
MHK has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
MHK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -900K shares |
| 1 year | -3.7% | -2.3M shares |
| 3 years | -5.8% | -3.7M shares |
| 5 years | -13% | -8.9M shares |
| Available history | -17% | -12.3M shares |
MHK has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $260.9M |
| Q2 2026 | $59.9M |
| Q1 2026 | $64.7M |
| Q4 2025 | $41.1M |
| Q3 2025 | $40.6M |
| Q2 2025 | $42.6M |
| Q1 2025 | $25.5M |
| Q4 2024 | $74.9M |
MHK spent $427M buying back its own shares over the past year, up 132% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over MHK on leverage, with a lower net debt burden relative to earnings.
MHK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.8x | Very low |
| Q2 2026 | 0.9x | Very low |
| Q1 2026 | 1.0x | Healthy |
| Q4 2025 | 1.0x | Healthy |
| Q3 2025 | 1.2x | Healthy |
| Q2 2025 | 1.3x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.2x | Healthy |
MHK's net debt is less than a year of its operating earnings (EBITDA), down from 1.2 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
MHK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.4 | Neutral |
| Stochastic | 84.5 | Overbought |
MHK's weekly RSI is 64 (neutral) and its Stochastic is 85 (overbought).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
MHK PE vs Consumer Cyclical Sector
| Metric | MHK | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 4.6% below |
| PE % | 69 | 47 | 22 pts above |
MHK has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
MHK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $131.4 | 12% above |
| 20 week MA | $127.9 | 15% above |
| 50 week MA | $117.5 | 25% above |
| 100 week MA | $116.8 | 26% above |
| 200 week MA | $115.1 | 27% above |
MHK is in an uptrend: it's above all five of its weekly moving averages, and 27% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
MHK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $134.4 | $138.7 | +3.2% |
| 2021 | $138.7 | $171.2 | +23% |
| 2022 | $171.2 | $98.0 | -43% |
| 2023 | $98.0 | $103.5 | +5.7% |
| 2024 | $103.5 | $118.8 | +15% |
| 2025 | $118.8 | $110.2 | -7.2% |
| 2026 YTD | $110.2 | $146.6 | +33% |
MHK has the edge over AMZN on returns for 2026, with the stronger performance.